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Nonsense Mutations in FAM161A Cause
RP28-Associated Recessive Retinitis Pigmentosa
Thomas Langmann,1,9 Silvio Alessandro Di Gioia,2,9 Isabella Rau,3,9 Heidi Sto¨hr,1
Nela S. Maksimovic,3,11 Joseph C. Corbo,4 Agnes B. Renner,5 Eberhart Zrenner,6
Govindasamy Kumaramanickavel,7 Marcus Karlstetter,1 Yvan Arsenijevic,8 Bernhard H.F. Weber,1
Andreas Gal,3,10,* and Carlo Rivolta2,10,*
Retinitis pigmentosa (RP) is a degenerative disease of the retina leading to progressive loss of vision and, in many instances, to legal
blindness at the end stage. The RP28 locus was assigned in 1999 to the short arm of chromosome 2 by homozygosity mapping in a large
Indian family segregating autosomal-recessive RP (arRP). Following a combined approach of chromatin immunoprecipitation and
parallel sequencing of genomic DNA, we identified a gene, FAM161A, which was shown to carry a homozygous nonsense mutation
(p.Arg229X) in patients from the original RP28 pedigree. Another homozygous FAM161A stop mutation (p.Arg437X) was detected in
three subjects from a cohort of 118 apparently unrelated German RP patients. Age at disease onset in these patients was in the second
to third decade, with severe visual handicap in the fifth decade and legal blindness in the sixth to seventh decades. FAM161A is a phylo-
genetically conserved gene, expressed in the retina at relatively high levels and encoding a putative 76 kDa protein of unknown func-
tion. In the mouse retina, Fam161amRNA is developmentally regulated and controlled by the transcription factor Crx, as demonstrated
by chromatin immunoprecipitation and organotypic reporter assays on explanted retinas. Fam161a protein localizes to photoreceptor
cells during development, and in adult animals it is present in the inner segment as well as the outer plexiform layer of the retina, the
synaptic interface between photoreceptors and their efferent neurons. Taken together, our data indicate that null mutations in FAM161A
are responsible for the RP28-associated arRP.Retinitis pigmentosa (RP [MIM 268000]) is a hereditary
blinding condition that affects approximately 1 million
individuals worldwide. It is genetically heterogeneous,
with mutations in more than 45 genes identified to date
according to the RetNet database. Nevertheless, these
mutations account for only about 50% of the existing
disease alleles.1 Many of the known RP genes are expressed
in rod photoreceptors, although during the disease process
both rod and cones progressively degenerate as a result of
mechanisms that are only partly known.2 The RP28 locus
(MIM 606068) was mapped to chromosome 2p11-p15 in
a large consanguineous family (PMK146) from India segre-
gating autosomal-recessive RP (arRP),3 whereas the corre-
sponding gene and the underlying genetic defect were
not identified. Homozygosity mapping defined a 15 Mb
interval between D2S1337 and D2S286 harboring 188
annotated sequences or putative genes. To search for the
gene implicated in the RP28 phenotype, we implemented
a synergistic strategy based on ultrahigh-throughput
sequencing (UHTs) of microarray-captured genomic DNA
and chromatin immunoprecipitation coupled to UHTs
(ChIP-Seq). Specifically, results from UHTs-based muta-
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for the retinal transcription factor Crx4 for the identifica-
tion of candidate genes localized within the RP28 interval.
This approach was based on our observation that phyloge-
netically conserved Crx-bound regions (CBRs) detected by
ChIP-Seq were present in 95% (61/64) of retina-enriched
genes and in the majority of known RP-associated genes,
suggesting that nearly all identified retinal disease genes
with retina-enriched expression are direct Crx targets.
Our study involved human subjects and was carried out
in accordance with the tenets of the Declaration of
Helsinki and the ethical guidelines of our institutions.
Written informed consent was obtained from all par-
ticipants. Traces of DNA from patient V-4 of family
PMK1463 were amplified by whole-genome amplification
(QIAGEN, Venlo, The Netherlands). Fifteen micrograms
of DNA were used in a sequence-capture experiment
(SureSelect, Agilent, Santa Clara, CA, USA) with custom-
designed probes targeting all of the 1643 exons (and their
intronic vicinities) present in the RP28 interval. The
captured DNA was then further processed for UHTs with
a Genome Analyzer II (Illumina, San Diego, CA, USA)
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Figure 1. Schematic Representation of the RP28 Interval and Mutations in FAM161A
(A) Linkage interval for RP28 on chromosome 2p is delimited by microsatellite markers D2S1337 and D2S286 and spans over 15 Mb of
DNA. Black boxes represent the 188 genes screened by UHTs.
(B) Structure of the two protein-coding isoforms of FAM161A, which are transcribed in the reverse direction with respect to the indicated
orientation of chromosome 2, and location of the nonsense mutations detected in patients with arRP. Arrows indicate the primers used
in quantitative RT-PCR experiments for detection of FAM161AmRNA expression in human tissues. The forward primer for both RT-PCR
reactions lies on exon 3, whereas the reverse primer is complementary to either the 3-4 or the 3-3a exon-exon junctions, depending on
the isoform analyzed.
(C) Electropherograms of the c.685C>T (p.Arg229X) and c.1309A>T (p.Arg437X) mutations and the corresponding region in controls.NC_000002.11. We obtained 14.8 million reads, corre-
sponding to approximately 500 Mb of contiguous se-
quence, 62% of which could be aligned to exons from
the candidate chromosomal region. The reads were assem-
bled and evaluated as described previously5 and produced
a 450-fold coverage per bp on average. In total, eight non-
annotated homozygous variants were found with respect
to the reference sequence (Table S1, available online).
In a complementary approach, alignment of mouse
CBRs identified through ChIP-Seq and matched to the
orthologous human RP28 interval yielded 15 presumptive
Crx target genes (Table S2). The gene with the strongest
Crx binding, as reflected by 205 ChIP-Seq reads at the
corresponding mouse locus, was also the top candidate
from the UHTs mutational screening. It corresponded to
the uncharacterized gene FAM161A, bearing a homozygousThe Americanc.685C>T (NM_032180.2) substitution in exon 3 that
should result in the nonsense change p.Arg229X (Figure 1).
As expected, this mutation was present in all four affected
members of family PMK146 in a homozygous state,
whereas unaffected relatives of the patients were either
heterozygous or carried wild-type alleles. These data sug-
gest FAM161A to be the RP28 gene previously mapped to
2p11-p15 in this family.
Further screening of FAM161A in 118 presumably
unrelated patients from Germany with recessive or isolate
forms of RP revealed the presence of another homozygous
nonsense mutation (c.1309A>T [p.Arg437X]; Figure 1) in
exon 3 of three patients (M09-0352, arRP173, and
arRP323; Table 1) that cosegregated with the RP phenotype
in the respective families. This mutation was absent in 400
ethnically matched control chromosomes (p ¼ 5.43 103,Journal of Human Genetics 87, 376–381, September 10, 2010 377
Table 1. FAM161A Mutations in Patients with Retinitis
Pigmentosa
Index
Patient ID
Ethnic
Origin Exon
Nucleotide
Change Allele Status
Protein
Variant
V-4 Indian 3 c.685C>T homozygous p.Arg229X
M09-0352 German 3 c.1309A>T homozygous p.Arg437X
arRP173 German 3 c.1309A>T homozygous p.Arg437X
arRP323 German 3 c.1309A>T homozygous p.Arg437Xby chi-square). Both the c.685C>Tand c.1309A>Tchanges
represent likely functional null alleles with absence of the
gene product, because the mRNA is predicted to undergo
nonsense-mediated decay.6 The three German patients
carrying the p.Arg437Xmutation originated from different
geographical regions, but they shared the same FAM161A
haplotype composed of six intragenic SNPs (Table S3).
The G allele of rs11125895:A>G was present in German
controls (n ¼ 178) at a frequency of 0.167. The finding of
homozygosity in these apparently unrelated patients
suggests that p.Arg437X represents a mutation originating
from a common founder. Other DNA changes detected in
FAM161A included rare missense or isocoding changes of
unknown pathogenicity and SNPs (Tables S4 and S5).
Three of the nonsynonymous sequence variants affect
evolutionarily conserved residues and were not detected
in 400 control chromosomes. However, all were found in
a heterozygous state only. Thus, the significance of these
rare variants in the pathogenesis of the retinal phenotype
of the patients remains to be elucidated.
It seems that the FAM161A-type retinal dystrophy shows
no unique clinical features. The course of the disease is
rather slow, with severe visual handicap in the fifth decade
and legal blindness in the sixth to seventh decades. Patient
M09-0352 was a 19-year-old female who complained
about progressive constriction of the visual field, disturbed378 The American Journal of Human Genetics 87, 376–381, Septembnight vision, slight hearing problems, and hyposmia at
her first visit. She was the offspring of unaffected parents
with no history of consanguinity. Best corrected visual
acuity was 20/25 in both eyes. Funduscopy showed typical
findings of RP, such as bone spicules in the midperiphery,
narrowed vessels, and optic disc pallor. Fundus autofluores-
cence was mottled and reduced in the midperiphery and
showed a fine, small ring of increased autofluorescence
around the fovea. Goldmann perimetry demonstrated
distinct constricted visual fields in both eyes. The outer
borders were at 10 excentricity. Full-field electroretino-
gram was not recordable. Patients arRP173 and arRP323
were 70 and 69 years old, respectively. These women
were the only affected offspring of apparently unrelated
parents. In both cases, age at onset was reported to be in
the second to third decade. The diagnosis of RP was
made at the ages of 30 (arRP323) and 42 (arRP173) years.
Disease onset in the three affected siblings of the PMK146
family was reported to be around 15 years of age. At the
ages of 42 and 47 years, respectively, patients V-2 and
V-3 had a severe visual handicap but were not regarded
to be legally blind. They presented with fundus changes
typical for RP, including narrowing of the arteries, bone
spicule pigments, and optic atrophy. The age at onset
was considerably earlier (at the age of 5 years) in patient
VI-2, with a more rapid disease progression: at the age of
15 years, she could count fingers close to face (OD) and
had a visual acuity of 3/60 (OS). It therefore appears that
FAM161A defects lead to a variable phenotype in terms
of disease onset and progression. The differences could
be due to genetic or environmental modifiers.
FAM161A is an uncharacterized sequence with multiple
splicing variants, two of which are predicted to result in
stable mRNA transcripts. The most abundant derives
from six exons and encodes a predicted protein of
660 amino acid residues (76 kDa), whereas the second iso-
form contains a supplementary in-frame 168 bp exonFigure 2. FAM161A mRNA Expression in
Human and Mouse
(A and B) Quantitative RT-PCR in various
human tissues of the FAM161A short iso-
form (A) and long isoform (B). Both graphs
represent mRNA expression normalized to
the housekeeping gene ACTB. Note that
ranges of y axes are not the same.
(C) Fam161a expression in the mouse
retina, as detected by quantitative RT-
PCRwith the use of the 18S rRNA as house-
keeping gene at various developmental
stages.
(D) Affymetrix GeneChip expression data
from wild-type versus Crx/ P14 retinas,
as detected with the Fam161a-specific
probe set 1443569_at.
Error bars indicate standard errors of the
mean (A and B) and standard deviations
(C and D), calculated in all instances
from three independent experiments.
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Figure 3. CBRs around Fam161a and CBR-Driven
Reporter Expression in the Murine Retina
(A) Fam161a Crx-bound regions (CBR1 and CBR2,
black boxes), as detected by ChIP-Seq experiments
and phylogenetic conservation among mammals.
(B) Constructs carrying a constitutive CMV early
enhancer-chicken b actin (CAG) promoter-eGFP
fusion (electroporation control) and each of two
Fam161a CBRs-DsRed fusions were coelectroporated
in explanted P0 mouse retinas. CBR1 was cloned
immediately upstream of DsRed, whereas CBR2
(intronic enhancer) was cloned upstream of a
rhodopsin minimal promoter, which by itself is not
active (lower panels). Fluorescence was measured
after 8 days in wholemounts (left and central panels)
and cross-sections (right panels). CBR1 alone does
not seem to be active, whereas CBR2 can activate
transcription in a Crx-dependent manner. CBR2
activity is detected in the outer nuclear layer, but
not in the inner nuclear layer. This cis-regulatory
element could therefore be responsible for the photo-
receptor-specific expression of Fam161a.between exons 3 and 4 defining additional 56 residues
(Figure 1). Although in some species (including mouse)
orthologous entries are incorrectly or only partly anno-
tated, FAM161A is evolutionarily conserved in vertebrates
(Figure S1) and has a paralog, named FAM161B. The puta-
tive protein products of FAM161A and FAM161B share
approximately 30% identity over a 400 amino acid residue
stretch. Data derived from in silico databases suggest that
FAM161B is not expressed in the retina. The function of
protein family 161 is currently unknown.
Quantitative RT-PCR of the major isoform of the
FAM161A mRNA revealed elevated expression in the
human retina and testis, whereas in other tissues FAM161A
transcripts were present at lower abundance (Figure 2A).
Considering that testis is an organ expressing almost
85% of all human genes at various levels,7 biologically rele-
vant FAM161A expression in humans may be confined to
the retina. Although present at different levels, the two
protein-coding human isoforms of FAM161A showed
a similar expression profile (Figure 2B), and none of them
could be defined as retina-specific, as is the case for other
RP genes presenting with multiple splicing isoforms.8–10The American Journal of HumIn the mouse, Fam161a mRNA was highly ex-
pressed in the developing and adult retina
and its presence was critically dependent on
Crx (Figures 2C and 2D). As shown in
Figure 3A, four CBRs are present within the
Fam161a region, two of which are evolution-
arily conserved and reside in the promoter
(CBR1) and the first intron of the gene
(CBR2). To analyze whether these CBRs repre-
sent photoreceptor-specific cis-regulatory
elements, we performed electroporations of
CBR-reporter fusions into explanted living-
mouse postnatal day 0 (P0) retinas (Figure S2).
Remarkably, although it is part of theFam161apromoter region, CBR1 could not drive detectable
expression in photoreceptors alone. In contrast, we found
that CBR2 exerted strong photoreceptor-specific enhancer
activity, as demonstrated by prominent DsRed fluorescence
in the outer nuclear layer (ONL) (Figure 3B). These data
establish Fam161a as a direct Crx target gene and highlight
its retina-specific cis-regulatory regions.
We raised a polyclonal rabbit antibody against a con-
served part of FAM161A (peptide: N-NPITGARVAQYE-C,
100% identity between human andmouse) and performed
immunohistochemistry by using this antibody at a final
dilution of 1:40 and biotinylated goat anti-rabbit IgGs
(1:200). Specificity of the antibody for the target protein
was tested by competition experiments with the peptide
used for immunization, as well as by siRNA-mediated
silencing of FAM161A in cultured cells (not shown). Detec-
tion was achieved with the ABC-HRP Kit (Vector, Burlin-
game, CA, USA) and the use of 3,30-diaminobenzidine
(DAB) (Dako, Carpinteria, CA, USA). Staining revealed a
developmentally regulated expression of Fam161a within
the mouse retina. Specifically, we observed a light, diffuse
labeling in the neural basal layer at P0 (Figure 4A). Atan Genetics 87, 376–381, September 10, 2010 379
Figure 4. Fam161a Expression Pattern during Mouse Retinal Development and Retinal Degeneration
DAB immunostaining of Fam161a in murine retinas at various developmental stages, in wild-type animals (wt) and in models of retinal
degeneration.
(A and B) Fam161a isminimally expressed at P0 (A), whereas at P10 it shows amarked presence in the outer nuclear layer and in the inner
segments of photoreceptors (B). Note that the outer plexiform layer is also positive.
(C) In adult animals (P30), Fam161a reaches a well-defined localization in the inner segment of photoreceptors, as well as in the outer
plexiform layer. It is completely absent from the outer segment of photoreceptors.
(D) Magnification of portions of (C), showing details of positive Fam161a staining.
(E and F) Fam161a localization in retinas from the rd1 (rd) mouse at P12 and from the Rho/ (rho)mouse at P60. Arrows indicate nuclear
or perinuclear aggregates of Fam161a within photoreceptors. Magnification: A, B, and E, 2003; C and F, 4003; D, 8003. Abbreviations:
NBL, neural basal layer; OS, outer segment of photoreceptors; IS, inner segment of photoreceptors; ONL, outer nuclear layer; OPL, outer
plexiform layer; INL, inner nuclear layer; IPL, inner plexiform layer; GCL ganglion cell layer.P10, a marked labeling was detected in all cell bodies of the
outer nuclear layer (ONL), suggesting that Fam161a is ex-
pressed in both rods and cones. Note that the inner
segments of the photoreceptors also stained positive for
Fam161a (Figure 4B). In the adult retina (P30), Fam161a
was present in the inner segments but absent in the outer
segments of the photoreceptors (Figures 4C and 4D). It also
showed small, strongly labeled structures at the level of the
outer plexiform layer (OPL). However, further analysis is
needed to identify in which subcellular structure of the
OPL Fam161a is exactly localized. Several studies have
shown that instability of some photoreceptor proteins
may play an important role in the process of cell death
even if the protein in question is only indirectly linked
to the mutated gene targeted in a defined mouse model.
For instance, mislocalization of S and M opsins is thought
to play a role in cone degeneration in the Rpe65-deficient
mouse (RPE65 [MIM 180069]).11 We therefore analyzed
the rd1 mouse to explore whether Fam161a expression or
its subcellular localization may be affected in the early
process of retinal degeneration. Rd1 mice bear homozy-
gous mutations in the gene encoding the beta subunit of380 The American Journal of Human Genetics 87, 376–381, Septembthe rod cGMP-phosphodiesterase (PDE6B [MIM 180072])
and show a rapid degeneration of rod photoreceptors start-
ing at P10–11. Interestingly, the Fam161a expression
pattern was markedly affected in the rd1 mouse retina;
several cell bodies and nuclei showed only dot-like positive
signals (Figure 4E). Fam161a localization was also
abnormal in rhodopsin/ mice (RHO [MIM 180380]),
which have a slower degeneration process. Specifically,
Fam161a expression in adult Rho/ retinas was very
similar to that of immature wild-type retinas (P10), with
a uniform andmarked presence in all cells of the ONL (Fig-
ure 4F). Mislocalization of Fam161a in the retina of these
genetically manipulated animals can be part of the
pathology associated with the primary gene defect or
a nonspecific consequence of the degenerative process in
the retina. In particular, these observations may suggest
a link between Fam161a and proteins involved in the pho-
totransduction cascade. During adulthood, Fam161a is
localized in the inner segment, where both Pde6b and
rhodopsin migrate through to reach the outer segment.
Because the absence of each of these two latter proteins
results in maintaining Fam161a in the cell body,er 10, 2010
Fam161a trafficking may be dependent on certain photo-
transduction proteins. However, this hypothesis is highly
speculative and needs further experimental verification.
Analysis of a second consanguineous family from India
has suggested refined boundaries of the putative RP28-
chromosomal region and defined a smaller region of over-
lap, of ~3.5 Mb.12 DNA samples from the original RP28
family and the second Indian family showed different
haplotypes, excluding a FAM161A/RP28-founder mutation
segregating in both families.5 Furthermore, linkage data do
not support the assumption that FAM161A is implicated in
the retinal dystrophy in the second family.
In this report, we show that mutations in FAM161A
cause the RP28-associated form of arRP and that
FAM161A mutations are present in the population of
both India and Europe. The measured prevalence of
FAM161A-associated RP in our cohort of German patients
is in the range of 2%–3%, comparable to that of other
arRP genes. Our data also indicate that these mutations
are likely functional null alleles, making FAM161A an ideal
target for constructing knockout animal models and for
the option of gene replacement in the quest of seeking
treatment for this disease.Supplemental Data
Supplemental Data include two figures and five tables and can be
found with this article online at http://www.cell.com/AJHG/.Acknowledgments
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